Digirad Co. (NASDAQ:DRAD) insider Matthew G. Molchan acquired 20,000 shares of the stock in a transaction on Friday, March 15th. The shares were acquired at an average price of $0.85 per share, for a total transaction of $17,000.00. Following the acquisition, the insider now owns 162,396 shares of the company’s stock, valued at approximately $138,036.60. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink.
DRAD traded down $0.01 during trading on Monday, hitting $0.84. 114,897 shares of the company’s stock were exchanged, compared to its average volume of 82,534. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.60. Digirad Co. has a fifty-two week low of $0.42 and a fifty-two week high of $2.00.
An institutional investor recently bought a new position in Digirad stock. Price Wealth Management Inc. acquired a new position in shares of Digirad Co. (NASDAQ:DRAD) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 61,000 shares of the medical equipment provider’s stock, valued at approximately $35,000. Price Wealth Management Inc. owned about 0.30% of Digirad at the end of the most recent quarter. 38.83% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Digirad Co. (DRAD) Insider Matthew G. Molchan Purchases 20,000 Shares” was reported by Zolmax and is the property of of Zolmax. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://zolmax.com/investing/digirad-co-drad-insider-matthew-g-molchan-purchases-20000-shares/2973016.html.
Digirad Company Profile
Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services.
Recommended Story: How to interpret the current ratio
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.